Name | Title | Contact Details |
---|---|---|
Scott St Cyr |
SVP / Product CTO | Profile |
Terry Johnson |
Interim Chief Information Officer | Profile |
Taiho Oncology, Inc. strives to make a positive contribution to society and the environment. We support our local communities through charitable endeavors, and we work proactively to protect the environment by minimizing the environmental impact in every aspect of our work-from research and development to production, distribution, marketing, and disposal. Furthermore, as a member of Otsuka Holdings, we are part of a group of companies that pursues initiatives that are shaped by mutual respect and open communication with all stakeholders, including customers and business partners in the countries and regions where we do business.
Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.
Pharmaka is a Flemington, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hospital Patient Services is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sterling Pharmaceutical Services, LLC is a Maryville, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.